You are here: Industry Insights > GSK

News List

COVID-19 S-Trimer vaccine candidates show promise in early trials europeanpharmaceuticalreview
December 08, 2020
When adjuvanted with GSK’s pandemic adjuvant system, the S-Trimer vaccine candidates induced the production of neutralising antibodies in all trial participants.
Bora Pharmaceuticals completes acquisition of former GSK facility prnasia
December 02, 2020
Bora Pharmaceuticals Co., Ltd announced that the contract development and manufacturing organization (CDMO) has successfully completed the acquisition of GSK's Mississauga, Ontario (Canada) facility.
Exagen, GSK Partner to Raise Lupus Diagnosis, Management Awareness americanpharmaceuticalreview
November 26, 2020
Exagen has extended its collaboration agreement with GlaxoSmithKline (GSK) to raise awareness of the importance of timely diagnosis of systemic lupus erythematosus (SLE), the most common and severe form of lupus.
GSK launches late-stage study of RSV vaccine in pregnant mothers pharmatimes
November 25, 2020
GlaxoSmithKline (GSK) has kicked off a phase III study of its Respiratory Syncytial Virus (RSV) vaccine candidate for maternal immunisation.
University of Cambridge Announces Agreement with AstraZeneca, GSK americanpharmaceuticalreview
November 23, 2020
The University of Cambridge announced a five-year agreement with AstraZeneca and GSK to fund the Cambridge Centre for AI in Medicine (CCAIM).
Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate worldpharmanews
November 16, 2020
Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK have announced the start of Phase 2/3 clinical trials of its plant-derived vaccine candidate for COVID-19 to evaluate its efficacy, safety, and immunogenicity.
New EU approval for GSK's Zejula pharmatimes
November 04, 2020
GlaxoSmithKline's once-daily PARP inhibitor Zejula (niraparib) has been approved by the European Commission for first-line monotherapy maintenance treatment for adults with advanced ovarian cancer.
Sanofi, GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine americanpharmaceuticalreview
October 29, 2020
Sanofi and GSK have signed a Statement of Intent with Gavi, the legal administrator of the COVAX Facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of eventual COVID-19 vaccines.
GSK to begin final-stage trials of respiratory syncytial virus vaccine expresspharma
October 22, 2020
GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged by mid-stage trial results.
GSK to Sell Poznań Manufacturing Site to Delpharm contractpharma
October 16, 2020
The CDMO acquires all facilities and around 700 manufacturing employees.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page